Holding(s) in Company

Sep 23, 2026

Advanced Medical Solutions Group plc
(“AMS” or the “Group”)

<br />

@page Section_1 { size: 595.3pt 841.9pt margin-top: 92.15pt margin-right: 62.35pt margin-bottom: 68.05pt margin-left: 62.35pt -aw-footer-distance: 35.45pt -aw-header-distance: 14.15pt }
.aspose-root div.Section_1 { margin: 92.15pt 62.35pt 68.05pt; page: Section_1 }
.aspose-root { font-family: Georgia; font-size: 11pt; max-width: 600.3pt; width: 600.3pt; margin: 1pt auto; position: relative; display: block }
.aspose-root h1, .aspose-root h2, .aspose-root h3, .aspose-root h4, .aspose-root h5, .aspose-root h6, .aspose-root p { margin: 0 }
.aspose-root li, .aspose-root table { margin-top: 0; margin-bottom: 0 }
.aspose-root h1 { margin-top: 12pt; margin-bottom: 3pt; page-break-inside: auto; page-break-after: avoid; font-family: Arial; font-size: 16pt; font-weight: bold; color: rgba(0, 0, 0, 1) }
.aspose-root h2 { margin-top: 12pt; margin-bottom: 3pt; page-break-inside: auto; page-break-after: avoid; font-family: Arial; font-size: 14pt; font-weight: bold; font-style: italic; color: rgba(0, 0, 0, 1) }
.aspose-root h3 { margin-top: 12pt; margin-bottom: 3pt; text-indent: -14.15pt; page-break-inside: auto; page-break-after: avoid; font-family: Arial; font-size: 13pt; font-weight: bold; color: rgba(0, 0, 0, 1) }
.aspose-root h4 { margin-top: 12pt; margin-left: 14.85pt; margin-bottom: 3pt; text-indent: -43.2pt; page-break-inside: auto; page-break-after: avoid; font-family: “Times New Roman”; font-size: 14pt; font-weight: bold; font-style: normal; color: rgba(0, 0, 0, 1) }
.aspose-root h5 { margin-top: 12pt; margin-left: 22.05pt; margin-bottom: 3pt; text-indent: -50.4pt; page-break-inside: auto; page-break-after: auto; font-family: Georgia; font-size: 13pt; font-weight: bold; font-style: italic; color: rgba(0, 0, 0, 1) }
.aspose-root h6 { margin-top: 12pt; margin-left: 29.25pt; margin-bottom: 3pt; text-indent: -57.6pt; page-break-inside: auto; page-break-after: auto; font-family: “Times New Roman”; font-size: 11pt; font-weight: bold; color: rgba(0, 0, 0, 1) }
.aspose-root .Heading7 { margin-top: 12pt; margin-left: 36.45pt; margin-bottom: 3pt; text-indent: -64.8pt; page-break-inside: auto; page-break-after: auto; font-family: “Times New Roman”; font-size: 11pt; font-weight: normal; font-style: normal; color: rgba(0, 0, 0, 1); -aw-style-name: heading7 }
.aspose-root .Heading8 { margin-top: 12pt; margin-left: 43.65pt; margin-bottom: 3pt; text-indent: -72pt; page-break-inside: auto; page-break-after: auto; font-family: “Times New Roman”; font-size: 11pt; font-weight: normal; font-style: italic; color: rgba(0, 0, 0, 1); -aw-style-name: heading8 }
.aspose-root .Heading9 { margin-top: 12pt; margin-left: 50.85pt; margin-bottom: 3pt; text-indent: -79.2pt; page-break-inside: auto; page-break-after: auto; font-family: Arial; font-size: 11pt; font-weight: normal; font-style: normal; color: rgba(0, 0, 0, 1); -aw-style-name: heading9 }
.aspose-root .30 0Footer { line-height: 10pt; font-family: Georgia; font-size: 8pt; color: rgba(0, 0, 0, 1); -aw-style-name: ’00_Footer’ }
.aspose-root .30 0aPagenumber { text-align: right; line-height: 14pt; font-family: Georgia; font-size: 10pt; color: rgba(0, 0, 0, 1); -aw-style-name: ’00a_Page number’ }
.aspose-root .30 0bDBInfo { text-align: right; line-height: 14pt; font-family: Georgia; font-size: 10pt; color: rgba(255, 255, 255, 1); -aw-style-name: ’00b_DB_Info’ }
.aspose-root .30 1aDBTitle { text-align: right; line-height: 20pt; font-family: Georgia; font-size: 20pt; font-weight: bold; color: rgba(0, 0, 0, 1); -aw-style-name: ’01a_DB_Title’ }
.aspose-root .30 1bDBSubtitle { text-align: right; font-family: Georgia; font-size: 12pt; color: rgba(0, 0, 0, 1); -aw-style-name: ’01b_DB_Subtitle’ }
.aspose-root .30 2Date { line-height: 11pt; font-family: Georgia; font-size: 8.5pt; -aw-style-name: ’02_Date’ }
.aspose-root .30 3Headbold { margin-bottom: 0; text-align: justify; line-height: normal; font-family: Georgia; font-size: 10pt; font-weight: bold; -aw-style-name: ’03_Head_bold’ }
.aspose-root .30 3aHead { margin-bottom: 0; text-align: justify; line-height: normal; font-family: Georgia; font-size: 10pt; font-weight: normal; -aw-style-name: ’03a_Head’ }
.aspose-root .30 4BodyText { margin-bottom: 12.5pt; text-align: justify; line-height: 115%; font-family: Georgia; font-size: 10pt; -aw-style-name: ’04_Body Text’ }
.aspose-root .30 4Runningtext { text-align: justify; line-height: 150%; font-family: Georgia; font-size: 10pt; -aw-style-name: ’04_Running text’ }
.aspose-root .30 4aNumbering { margin-left: 14.2pt; margin-bottom: 12.5pt; text-indent: -14.2pt; text-align: justify; line-height: 115%; font-family: Georgia; font-size: 10pt; -aw-style-name: ’04a_Numbering’ }
.aspose-root .30 4aNumeration { margin-left: 14.2pt; text-indent: -14.2pt; text-align: justify; line-height: 115%; font-family: Georgia; font-size: 10pt; -aw-style-name: ’04a_Numeration’ }
.aspose-root .30 4anumeration0 { margin-top: 5pt; margin-bottom: 5pt; font-family: “Times New Roman”; font-size: 12pt; -aw-style-name: ’04anumeration’ }
.aspose-root .30 4bList { margin-left: 28.35pt; margin-bottom: 12.5pt; text-indent: -17pt; text-align: justify; line-height: 115%; font-family: Georgia; font-size: 10pt; -aw-style-name: ’04b_List’ }
.aspose-root .30 4bListing { margin-left: 14.2pt; margin-bottom: 12.5pt; text-indent: -14.2pt; text-align: justify; line-height: 115%; font-family: Georgia; font-size: 10pt; -aw-style-name: ’04b_Listing’ }
.aspose-root .30 4cA { margin-left: 17pt; text-indent: 11.35pt; line-height: 115%; font-family: Georgia; font-size: 10pt; -aw-style-aliases: ‘B’ ‘C’; -aw-style-name: ’04c_A’ }
.aspose-root .30 4dBodyTextbold { margin-bottom: 12.5pt; text-align: justify; line-height: 115%; font-family: Georgia; font-size: 10pt; font-weight: bold; -aw-style-name: ’04d_Body Text bold’ }
.aspose-root .30 4eBodytextleft { margin-bottom: 0; text-align: left; line-height: 115%; font-family: Georgia; font-size: 10pt; -aw-style-name: ’04e_Body text left’ }
.aspose-root .30 4fBodytextline { margin-bottom: 12.5pt; text-align: justify; line-height: 115%; border-bottom: 0.75pt solid rgba(0, 0, 0, 1); padding-bottom: 12pt; font-family: Georgia; font-size: 10pt; color: rgba(0, 0, 0, 1); -aw-border-bottom: 0.5pt single #000000; -aw-style-name: ’04f_Body text line’ }
.aspose-root .30 5HeadlinenoIndex { margin-bottom: 12.5pt; text-align: justify; line-height: 15pt; font-family: Georgia; font-size: 12pt; font-weight: bold; -aw-style-name: ’05_Headline no Index’ }
.aspose-root .30 5Subject { text-align: justify; line-height: 150%; font-family: Georgia; font-size: 12pt; font-weight: bold; -aw-style-name: ’05_Subject’ }
.aspose-root .30 5aTitle { line-height: 17pt; font-family: Georgia; font-size: 14pt; font-weight: bold; color: rgba(0, 0, 0, 1); -aw-style-name: ’05a_Title’ }
.aspose-root .30 5bHeadline1black { margin-left: 14.2pt; margin-bottom: 14pt; text-indent: -14.2pt; text-align: justify; page-break-after: avoid; line-height: 14pt; font-family: Georgia; font-size: 10pt; font-weight: bold; color: rgba(0, 0, 0, 1); -aw-style-name: ’05b_Headline 1 black’ }
.aspose-root .30 5cHeadline1 { margin-bottom: 14pt; text-indent: -28.35pt; text-align: justify; page-break-after: avoid; line-height: 14pt; font-family: Georgia; font-size: 10pt; font-weight: bold; -aw-style-name: ’05c_Headline 1′ }
.aspose-root .30 5dHeadline1line { margin-left: 14.2pt; margin-bottom: 14pt; text-indent: -14.2pt; text-align: justify; page-break-after: avoid; line-height: 14pt; border-top: 0.75pt solid rgba(0, 0, 0, 1); padding-top: 10pt; font-family: Georgia; font-size: 10pt; font-weight: bold; color: rgba(0, 0, 0, 1); -aw-border-top: 0.5pt single #000000; -aw-style-name: ’05d_Headline 1 line’ }
.aspose-root .30 5eHeadline2 { margin-bottom: 12.5pt; text-indent: -14.15pt; line-height: 12.5pt; font-family: Georgia; font-size: 10pt; -aw-style-name: ’05e_Headline 2′ }
.aspose-root .30 6InfoTitle { margin-bottom: 2pt; text-align: justify; font-family: Georgia; font-size: 12pt; font-weight: bold; -aw-style-name: ’06_Info_Title’ }
.aspose-root .30 6aInfoTitle { margin-bottom: 2pt; text-align: justify; font-family: Georgia; font-size: 8pt; font-weight: bold; -aw-style-name: ’06a_Info_Title’ }
.aspose-root .30 6aRunningtextblue { margin-bottom: 12.5pt; text-align: justify; line-height: 115%; border-bottom: 0.75pt solid rgba(40, 53, 131, 1); padding-bottom: 12pt; font-family: Georgia; font-size: 10pt; color: rgba(45, 65, 144, 1); -aw-border-bottom: 0.5pt single #283583; -aw-style-name: ’06a_Running text blue’ }
.aspose-root .BalloonText { line-height: normal; font-family: Tahoma; font-size: 8pt; -aw-style-name: balloon-text }
.aspose-root .CommentSubject { font-family: Georgia; font-size: 10pt; font-weight: bold; -aw-style-name: comment-subject; -aw-style-parent: comment-text }
.aspose-root .CommentText { line-height: normal; font-family: Georgia; font-size: 10pt; -aw-style-name: comment-text }
.aspose-root .DocumentMap { line-height: normal; font-family: Tahoma; font-size: 10pt; background-color: rgba(0, 0, 128, 1); -aw-style-name: document-map }
.aspose-root .Footer { line-height: normal; font-family: Georgia; font-size: 11pt; -aw-style-name: footer }
.aspose-root .FootnoteText { line-height: 10pt; font-family: Georgia; font-size: 8pt; -aw-style-aliases: ‘Testo_note’ ‘ft’; -aw-style-name: footnote-text }
.aspose-root .Header { line-height: normal; font-family: Georgia; font-size: 11pt; -aw-style-name: header }
.aspose-root .ListParagraph { margin-left: 36pt; line-height: 15pt; font-family: “Times New Roman”; font-size: 11pt; -aw-style-name: list-paragraph }
.aspose-root .NormalWeb { margin-top: 5pt; margin-bottom: 5pt; font-family: “Times New Roman”; font-size: 12pt; -aw-style-name: normal-web }
.aspose-root .Prrafodelista1 { margin-left: 35.4pt; font-family: Georgia; font-size: 11pt; -aw-style-name: ‘Párrafo de lista1′ }
.aspose-root .Revision { font-family: Georgia; font-size: 11pt; -aw-style-name: revision }
.aspose-root .TOC1 { line-height: 12.5pt; font-family: Georgia; font-size: 10pt; -aw-style-name: toc1 }
.aspose-root .TOC2 { margin-left: 11pt; font-family: Georgia; font-size: 11pt; -aw-style-name: toc2 }
.aspose-root .agendaitem { margin-top: 2pt; margin-bottom: 2pt; font-family: Tahoma; font-size: 9pt }
.aspose-root span.30 4BodyTextChar { font-family: Georgia; font-size: 12pt; -aw-style-name: ’04_Body Text Char’ }
.aspose-root span.30 6InfoTitleZchn { font-family: Georgia; font-size: 12pt; font-weight: bold; -aw-style-name: ’06_Info_Title Zchn’ }
.aspose-root span.30 6aInfoTitleZchn { font-family: Georgia; font-size: 12pt; font-weight: bold; -aw-style-name: ’06a_Info_Title Zchn’ }
.aspose-root span.BalloonTextChar { font-family: Tahoma; font-size: 8pt }
.aspose-root span.CommentReference { font-size: 8pt; -aw-style-name: comment-reference }
.aspose-root span.CommentSubjectChar { font-family: Georgia; font-size: 10pt; font-weight: bold }
.aspose-root span.CommentTextChar { font-family: Georgia; font-size: 10pt }
.aspose-root span.DocumentMapChar { font-size: 1pt }
.aspose-root span.EndnoteReference { vertical-align: super; -aw-style-name: endnote-reference }
.aspose-root span.FollowedHyperlink { text-decoration: underline; color: rgba(128, 0, 128, 1); -aw-style-name: followed-hyperlink }
.aspose-root span.FooterChar { font-family: Georgia; font-size: 12pt }
.aspose-root span.FootnoteReference { vertical-align: super; -aw-style-aliases: ’16 Point’ ‘Superscript 6 Point’ ‘Footnote Reference Number’ ‘Footnote Reference_LVL6’ ‘Footnote Reference_LVL61’ ‘Footnote Reference_LVL62’ ‘Footnote Reference_LVL63’ ‘Footnote Reference_LVL64’; -aw-style-name: footnote-reference }
.aspose-root span.FootnoteTextChar { font-family: Georgia; font-size: 10pt; -aw-style-aliases: ‘Testo_note Char’ ‘ft Char’ }
.aspose-root span.HeaderChar { font-family: Georgia; font-size: 12pt }
.aspose-root span.Heading1Char { font-family: Cambria; font-size: 16pt; font-weight: bold }
.aspose-root span.Heading2Char { font-family: Cambria; font-size: 14pt; font-weight: bold; font-style: italic }
.aspose-root span.Heading3Char { font-family: Arial; font-size: 13pt; font-weight: bold }
.aspose-root span.Heading4Char { font-size: 14pt; font-weight: bold }
.aspose-root span.Heading5Char { font-family: Georgia; font-size: 13pt; font-weight: bold; font-style: italic }
.aspose-root span.Heading6Char { font-weight: bold }
.aspose-root span.Heading8Char { font-style: italic }
.aspose-root span.Heading9Char { font-family: Arial }
.aspose-root span.Hyperlink { text-decoration: underline; color: rgba(0, 0, 255, 1); -aw-style-name: hyperlink }
.aspose-root span.IntenseReference { font-weight: bold; font-variant: small-caps; text-decoration: underline; letter-spacing: 0.25pt; color: rgba(0, 0, 0, 1); -aw-style-name: intense-reference }
.aspose-root span.PageNumber { -aw-style-name: page-number }
.aspose-root span.Strong { font-weight: bold; -aw-style-name: strong }
.aspose-root span.UnresolvedMention { color: rgba(128, 128, 128, 1); background-color: rgba(230, 230, 230, 1); -aw-style-name: unresolved-mention }
.aspose-root .TableGrid { }

.aspose-root .rn-1 { font-family: Arial; font-weight: bold }
.aspose-root .rn-2 { font-size: 10pt }
.aspose-root .rn-3 { font-family: Arial; font-weight: bold; -aw-import: ignore }
.aspose-root .rn-4 { width: 520.2pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-5 { font-family: Arial }
.aspose-root .rn-6 { font-family: Arial; text-decoration: underline }
.aspose-root .rn-7 { font-family: Arial; font-size: 6.67pt; vertical-align: super }
.aspose-root .rn-8 { text-align: right; font-size: 10pt }
.aspose-root .rn-9 { font-family: Arial; -aw-import: ignore }
.aspose-root .rn-10 { width: 259.1pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-11 { width: 250.3pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-12 { text-align: center; font-size: 10pt }
.aspose-root .rn-13 { width: 485.9pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-14 { width: 23.5pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-15 { height: 22pt }
.aspose-root .rn-16 { height: 19.5pt }
.aspose-root .rn-17 { width: 259.1pt; border-top: 0.75pt solid rgba(0, 0, 0, 1); border-right: 0.75pt solid rgba(0, 0, 0, 1); border-left: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border-bottom-style: nil; -aw-border-left: 0.5pt single #000000; -aw-border-right: 0.5pt single #000000; -aw-border-top: 0.5pt single #000000 }
.aspose-root .rn-18 { width: 250.3pt; border-top: 0.75pt solid rgba(0, 0, 0, 1); border-right: 0.75pt solid rgba(0, 0, 0, 1); border-left: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border-bottom-style: nil; -aw-border-left: 0.5pt single #000000; -aw-border-right: 0.5pt single #000000; -aw-border-top: 0.5pt single #000000 }
.aspose-root .rn-19 { height: 27.75pt }
.aspose-root .rn-20 { width: 95.4pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-21 { width: 104.85pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-22 { width: 95.5pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-23 { width: 85.85pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-24 { height: 0 }
.aspose-root .rn-25 { width: 106.2pt }
.aspose-root .rn-26 { height: 23.5pt }
.aspose-root .rn-27 { width: 99.65pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-28 { width: 90.35pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-29 { width: 90.8pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-30 { width: 115.2pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-31 { width: 81pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-32 { height: 10.9pt }
.aspose-root .rn-33 { width: 520.2pt; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top }
.aspose-root .rn-34 { height: 26.5pt }
.aspose-root .rn-35 { width: 48.6pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-36 { width: 119.6pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-37 { width: 128.15pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-38 { height: 24.05pt }
.aspose-root .rn-39 { height: 34.5pt }
.aspose-root .rn-40 { width: 88.2pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-41 { width: 60.05pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-42 { width: 60.1pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-43 { width: 88.4pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-44 { width: 88.45pt; border-top: 0.75pt solid rgba(0, 0, 0, 1); border-left: 0.75pt solid rgba(0, 0, 0, 1); border-bottom: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.4pt; padding-left: 5.03pt; vertical-align: middle; -aw-border-bottom: 0.5pt single #000000; -aw-border-left: 0.5pt single #000000; -aw-border-top: 0.5pt single #000000 }
.aspose-root .rn-45 { width: 145.15pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-46 { width: 132.95pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-47 { width: 94.65pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-48 { width: 117.65pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-49 { width: 522.8pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-50 { width: 238.4pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }
.aspose-root .rn-51 { width: 273.6pt; border: 0.75pt solid rgba(0, 0, 0, 1); padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; -aw-border: 0.5pt single #000000 }

RNS Number : 0236W
Advanced Medical Solutions Grp PLC
23 September 2026
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

Advanced Medical Solutions Group Plc

ISIN: GB0004536594

1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an “X”)

An acquisition or disposal of voting rights

 

An acquisition or disposal of financial instruments

X

An event changing the breakdown of voting rights

 

Other (please specify) iii:

 

3. Details of person subject to the notification obligation iv

Name

Verition Fund Management LLC

City and country of registered office (if applicable)

Wilmington, United States of America

4. Full name of shareholder(s) (if different from 3.) v

Name

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached vi:

21/09/2026

6. Date on which issuer notified (DD/MM/YYYY):

22/09/2026

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

0.000000%

4.152968%

4.152968%

9,173,537

Position of previous notification (if

applicable)

0.000000%

3.134835%

3.134835%

 

 

 

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type of
shares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

 

 

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expiration
date x

Exercise/
Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expiration
date x

Exercise/
Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

Contract for Difference

 

 

Cash Settlement

9,173,537

4.152968%

 

 

 

 

SUBTOTAL 8.B.2

9,173,537

4.152968%

 

 

 

 

 

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an “X”)

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

 

Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Verition Fund Management LLC

0.000000%

4.152968%

4.152968%

Verition Multi-Strategy Master Fund Ltd

0.000000%

4.152968%

4.152968%

 

10. In case of proxy voting, please identify:

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional information xvi

 

 

Place of completion

United Kingdom

Date of completion

22/09/2026

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 
 

HOLUOAURNRUKUAR

For further information, please contact:

Advanced Medical Solutions Group plc

Tel: 44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer

Michael King, Investor Relations

Consilium Strategic Communications

Tel: 44 (0) 20 3709 5700

Matthew Neal / Lucy Featherstone

Investec Bank PLC (NOMAD & Broker)

Tel: 44 (0) 20 7597 5970

Gary Clarence / David Anderson

HSBC Bank PLC (Broker)

Tel: 44 (0) 20 7991 8888

Sam McLennan / Joe Weaving / Stephanie Cornish

About Advanced Medical Solutions Group plc

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8® and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label. Since 2019, the Group has made five acquisitions: Sealantis, an Israeli developer of innovative internal sealants; Biomatlante, a French developer and manufacturer of surgical biomaterials, Raleigh, a leading UK coater and converter of woundcare and bio-diagnostics materials, AFS Medical, an Austrian specialist surgical business and Connexicon, an Irish tissue adhesives specialist.

AMS's products, manufactured in the UK, Germany, France, the Netherlands, the Czech Republic and Israel, are sold globally via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, Austria, the Czech Republic and Russia. The Group has R&D innovation hubs in the UK, Ireland, Germany, France and Israel. Established in 1991, the Group has more than 800 employees. For more information, please see admedsol.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.